次世代バイオ製造の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2582)
◆英語タイトル:Global Next-Generation Biomanufacturing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2582
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、次世代バイオ製造の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(上流バイオマニュファクチャリング、下流バイオマニュファクチャリング)、用途別市場規模(収益管理、サービスフルフィルメント、サービス保証、顧客管理、ネットワーク管理システム)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・次世代バイオ製造の市場動向
・企業の競争状況、市場シェア
・次世代バイオ製造の種類別市場規模(上流バイオマニュファクチャリング、下流バイオマニュファクチャリング)
・次世代バイオ製造の用途別市場規模(収益管理、サービスフルフィルメント、サービス保証、顧客管理、ネットワーク管理システム)
・次世代バイオ製造の北米市場規模2016-2027(アメリカ、カナダ)
・次世代バイオ製造の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・次世代バイオ製造のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・次世代バイオ製造の中南米市場規模2016-2027(メキシコ、ブラジル)
・次世代バイオ製造の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Merck、Thermo Fisher Scientific、Danaher、Eppendorf、Sartorius、GEA Group、bbi-biotech、Esco Group of Companies、Solaris Biotechnology、PBS Biotech、Applikon Biotechnology、Meissner Filtration Products、Shanghai Bailun Biotechnology)
・結論
【レポートの概要】

The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.

Market Analysis and Insights: Global Next-Generation Biomanufacturing Market
The global Next-Generation Biomanufacturing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next-Generation Biomanufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next-Generation Biomanufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next-Generation Biomanufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next-Generation Biomanufacturing market.

Global Next-Generation Biomanufacturing Scope and Market Size
Next-Generation Biomanufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Next-Generation Biomanufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Upstream Biomanufacturing
Downstream Biomanufacturing

Segment by Application
Biopharmaceutical Companies
CMOs/CDMOs
Research Institutions

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Thermo Fisher Scientific
Danaher
Eppendorf
Sartorius
GEA Group
bbi-biotech
Esco Group of Companies
Solaris Biotechnology
PBS Biotech
Applikon Biotechnology
Meissner Filtration Products
Shanghai Bailun Biotechnology

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Biomanufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Upstream Biomanufacturing
1.2.3 Downstream Biomanufacturing
1.3 Market by Application
1.3.1 Global Next-Generation Biomanufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical Companies
1.3.3 CMOs/CDMOs
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Next-Generation Biomanufacturing Market Perspective (2016-2027)
2.2 Next-Generation Biomanufacturing Growth Trends by Regions
2.2.1 Next-Generation Biomanufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Next-Generation Biomanufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Next-Generation Biomanufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Next-Generation Biomanufacturing Industry Dynamic
2.3.1 Next-Generation Biomanufacturing Market Trends
2.3.2 Next-Generation Biomanufacturing Market Drivers
2.3.3 Next-Generation Biomanufacturing Market Challenges
2.3.4 Next-Generation Biomanufacturing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Biomanufacturing Players by Revenue
3.1.1 Global Top Next-Generation Biomanufacturing Players by Revenue (2016-2021)
3.1.2 Global Next-Generation Biomanufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Next-Generation Biomanufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Biomanufacturing Revenue
3.4 Global Next-Generation Biomanufacturing Market Concentration Ratio
3.4.1 Global Next-Generation Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Biomanufacturing Revenue in 2020
3.5 Next-Generation Biomanufacturing Key Players Head office and Area Served
3.6 Key Players Next-Generation Biomanufacturing Product Solution and Service
3.7 Date of Enter into Next-Generation Biomanufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Next-Generation Biomanufacturing Breakdown Data by Type
4.1 Global Next-Generation Biomanufacturing Historic Market Size by Type (2016-2021)
4.2 Global Next-Generation Biomanufacturing Forecasted Market Size by Type (2022-2027)

5 Next-Generation Biomanufacturing Breakdown Data by Application
5.1 Global Next-Generation Biomanufacturing Historic Market Size by Application (2016-2021)
5.2 Global Next-Generation Biomanufacturing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Next-Generation Biomanufacturing Market Size (2016-2027)
6.2 North America Next-Generation Biomanufacturing Market Size by Type
6.2.1 North America Next-Generation Biomanufacturing Market Size by Type (2016-2021)
6.2.2 North America Next-Generation Biomanufacturing Market Size by Type (2022-2027)
6.2.3 North America Next-Generation Biomanufacturing Market Size by Type (2016-2027)
6.3 North America Next-Generation Biomanufacturing Market Size by Application
6.3.1 North America Next-Generation Biomanufacturing Market Size by Application (2016-2021)
6.3.2 North America Next-Generation Biomanufacturing Market Size by Application (2022-2027)
6.3.3 North America Next-Generation Biomanufacturing Market Size by Application (2016-2027)
6.4 North America Next-Generation Biomanufacturing Market Size by Country
6.4.1 North America Next-Generation Biomanufacturing Market Size by Country (2016-2021)
6.4.2 North America Next-Generation Biomanufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Next-Generation Biomanufacturing Market Size (2016-2027)
7.2 Europe Next-Generation Biomanufacturing Market Size by Type
7.2.1 Europe Next-Generation Biomanufacturing Market Size by Type (2016-2021)
7.2.2 Europe Next-Generation Biomanufacturing Market Size by Type (2022-2027)
7.2.3 Europe Next-Generation Biomanufacturing Market Size by Type (2016-2027)
7.3 Europe Next-Generation Biomanufacturing Market Size by Application
7.3.1 Europe Next-Generation Biomanufacturing Market Size by Application (2016-2021)
7.3.2 Europe Next-Generation Biomanufacturing Market Size by Application (2022-2027)
7.3.3 Europe Next-Generation Biomanufacturing Market Size by Application (2016-2027)
7.4 Europe Next-Generation Biomanufacturing Market Size by Country
7.4.1 Europe Next-Generation Biomanufacturing Market Size by Country (2016-2021)
7.4.2 Europe Next-Generation Biomanufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Biomanufacturing Market Size (2016-2027)
8.2 Asia-Pacific Next-Generation Biomanufacturing Market Size by Type
8.2.1 Asia-Pacific Next-Generation Biomanufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Next-Generation Biomanufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Next-Generation Biomanufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Next-Generation Biomanufacturing Market Size by Application
8.3.1 Asia-Pacific Next-Generation Biomanufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Next-Generation Biomanufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Next-Generation Biomanufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Next-Generation Biomanufacturing Market Size by Region
8.4.1 Asia-Pacific Next-Generation Biomanufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Next-Generation Biomanufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Next-Generation Biomanufacturing Market Size (2016-2027)
9.2 Latin America Next-Generation Biomanufacturing Market Size by Type
9.2.1 Latin America Next-Generation Biomanufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Next-Generation Biomanufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Next-Generation Biomanufacturing Market Size by Type (2016-2027)
9.3 Latin America Next-Generation Biomanufacturing Market Size by Application
9.3.1 Latin America Next-Generation Biomanufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Next-Generation Biomanufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Next-Generation Biomanufacturing Market Size by Application (2016-2027)
9.4 Latin America Next-Generation Biomanufacturing Market Size by Country
9.4.1 Latin America Next-Generation Biomanufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Next-Generation Biomanufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Biomanufacturing Market Size (2016-2027)
10.2 Middle East & Africa Next-Generation Biomanufacturing Market Size by Type
10.2.1 Middle East & Africa Next-Generation Biomanufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Next-Generation Biomanufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Next-Generation Biomanufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Next-Generation Biomanufacturing Market Size by Application
10.3.1 Middle East & Africa Next-Generation Biomanufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Next-Generation Biomanufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Next-Generation Biomanufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Next-Generation Biomanufacturing Market Size by Country
10.4.1 Middle East & Africa Next-Generation Biomanufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Next-Generation Biomanufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Next-Generation Biomanufacturing Introduction
11.1.4 Merck Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next-Generation Biomanufacturing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Next-Generation Biomanufacturing Introduction
11.3.4 Danaher Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.3.5 Danaher Recent Development
11.4 Eppendorf
11.4.1 Eppendorf Company Details
11.4.2 Eppendorf Business Overview
11.4.3 Eppendorf Next-Generation Biomanufacturing Introduction
11.4.4 Eppendorf Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.4.5 Eppendorf Recent Development
11.5 Sartorius
11.5.1 Sartorius Company Details
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Next-Generation Biomanufacturing Introduction
11.5.4 Sartorius Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.5.5 Sartorius Recent Development
11.6 GEA Group
11.6.1 GEA Group Company Details
11.6.2 GEA Group Business Overview
11.6.3 GEA Group Next-Generation Biomanufacturing Introduction
11.6.4 GEA Group Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.6.5 GEA Group Recent Development
11.7 bbi-biotech
11.7.1 bbi-biotech Company Details
11.7.2 bbi-biotech Business Overview
11.7.3 bbi-biotech Next-Generation Biomanufacturing Introduction
11.7.4 bbi-biotech Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.7.5 bbi-biotech Recent Development
11.8 Esco Group of Companies
11.8.1 Esco Group of Companies Company Details
11.8.2 Esco Group of Companies Business Overview
11.8.3 Esco Group of Companies Next-Generation Biomanufacturing Introduction
11.8.4 Esco Group of Companies Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.8.5 Esco Group of Companies Recent Development
11.9 Solaris Biotechnology
11.9.1 Solaris Biotechnology Company Details
11.9.2 Solaris Biotechnology Business Overview
11.9.3 Solaris Biotechnology Next-Generation Biomanufacturing Introduction
11.9.4 Solaris Biotechnology Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.9.5 Solaris Biotechnology Recent Development
11.10 PBS Biotech
11.10.1 PBS Biotech Company Details
11.10.2 PBS Biotech Business Overview
11.10.3 PBS Biotech Next-Generation Biomanufacturing Introduction
11.10.4 PBS Biotech Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.10.5 PBS Biotech Recent Development
11.11 Applikon Biotechnology
11.11.1 Applikon Biotechnology Company Details
11.11.2 Applikon Biotechnology Business Overview
11.11.3 Applikon Biotechnology Next-Generation Biomanufacturing Introduction
11.11.4 Applikon Biotechnology Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.11.5 Applikon Biotechnology Recent Development
11.12 Meissner Filtration Products
11.12.1 Meissner Filtration Products Company Details
11.12.2 Meissner Filtration Products Business Overview
11.12.3 Meissner Filtration Products Next-Generation Biomanufacturing Introduction
11.12.4 Meissner Filtration Products Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.12.5 Meissner Filtration Products Recent Development
11.13 Shanghai Bailun Biotechnology
11.13.1 Shanghai Bailun Biotechnology Company Details
11.13.2 Shanghai Bailun Biotechnology Business Overview
11.13.3 Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Introduction
11.13.4 Shanghai Bailun Biotechnology Revenue in Next-Generation Biomanufacturing Business (2016-2021)
11.13.5 Shanghai Bailun Biotechnology Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 次世代バイオ製造の世界市場規模・現状・予測2021年-2027年(Global Next-Generation Biomanufacturing Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。